Jacob Jobin John, Solaimalai Dhanalakshmi, Rachel Tanya, Pragasam Agila Kumari, Sugumar Saranya, Jeslin Praveena, Anandan Shalini, Veeraraghavan Balaji
Department of Clinical Microbiology, Christian Medical College, Vellore 632004, Tamil Nadu, India.
Department of Clinical Microbiology, Christian Medical College, Vellore 632004, Tamil Nadu, India.
Indian J Med Microbiol. 2022 Oct-Dec;40(4):536-540. doi: 10.1016/j.ijmmb.2022.07.015. Epub 2022 Aug 17.
Invasive non-typhoidal Salmonella (iNTS) disease is an important cause of morbidity and mortality in African countries. However, the incidence in Indian subcontinent remains poorly documented. This study has assessed the incidence of iNTS in India with a perspective on its AMR profiles and serovar distribution for a period of 21 years from 2000 to 2020 from a tertiary care centre in South India.
A total of 461 iNTS isolates were subjected to serotyping and antimicrobial susceptibility testing (AST). A subset of isolates was genotyped by multi locus sequence typing (MLST) and results were compared to serotyping to predict the accuracy.
Overall, 461 iNTS isolates were characterised mostly comprising of S. Typhimurium (49.2%) and S. Enteritidis (28.8%). Proportion of isolates resistant to first line antibiotics such as ampicillin, chloramphenicol and trimethoprim/sulphamethoxazole were 6.7%, 1.7% and 3.6% respectively. Isolates resistant to third generation cephalosporin are at a gradual rise while decreased susceptibility to quinolones was most common. The incidence of iNTS infection was maximum in the age group of >15 years. MLST analysis showed discrepancies in assigning the serovars by serotyping as three S. Saintpaul were identified as S. Typhimurium.
The clinical epidemiology, serovar distribution and antimicrobial susceptibility patterns of invasive Salmonella isolates from India suggest that there is only a small burden of iNTS disease. However the gradual emergence of AMR in iNTS isolates indicates serious risk for public health warranting the importance enhanced molecular surveillance.
侵袭性非伤寒沙门氏菌(iNTS)病是非洲国家发病和死亡的重要原因。然而,印度次大陆的发病率仍缺乏充分记录。本研究评估了印度iNTS的发病率,并从2000年至2020年的21年期间,对印度南部一家三级医疗中心的iNTS抗菌药物耐药性(AMR)概况和血清型分布进行了研究。
共对461株iNTS分离株进行血清分型和抗菌药物敏感性测试(AST)。对一部分分离株进行多位点序列分型(MLST)基因分型,并将结果与血清分型进行比较以预测准确性。
总体而言,461株iNTS分离株主要包括鼠伤寒沙门氏菌(49.2%)和肠炎沙门氏菌(28.8%)。对氨苄西林、氯霉素和甲氧苄啶/磺胺甲恶唑等一线抗生素耐药的分离株比例分别为6.7%、1.7%和3.6%。对第三代头孢菌素耐药的分离株呈逐渐上升趋势,而对喹诺酮类药物敏感性降低最为常见。iNTS感染的发病率在>15岁年龄组最高。MLST分析显示血清分型在血清型鉴定上存在差异,因为有3株圣保罗沙门氏菌被鉴定为鼠伤寒沙门氏菌。
来自印度的侵袭性沙门氏菌分离株的临床流行病学、血清型分布和抗菌药物敏感性模式表明,iNTS病的负担较小。然而,iNTS分离株中AMR的逐渐出现表明对公共卫生存在严重风险,这凸显了加强分子监测的重要性。